The impact of value-based healthcare for inflammatory bowel diseases on healthcare utilization: a pilot study

Background and objectives Value-based healthcare (VBHC) is considered to be the solution that will improve quality and decrease costs in healthcare. Many hospitals are implementing programs on the basis of this strategy, but rigorous scientific reports are still lacking. In this pilot study, we present the first-year outcomes of a VBHC program for inflammatory bowel disease (IBD) management that focuses on highly coordinated care, task differentiation of providers, and continuous home monitoring. Methods IBD patients treated within the VBHC program were identified in an administrative claims database from a commercial insurer allowing comparisons to matched controls. Only patients for whom data were available the year before and after starting the program were included. Healthcare utilization including visits, hospitalizations, laboratory and imaging tests, and medications were compared between groups. Results In total, 60 IBD patients treated at the VBHC Center were identified and were matched to 177 controls. Significantly fewer upper endoscopies were performed (-10%, P = 0.012), and numerically fewer surgeries (-25%, P = 0.49), hospitalizations (-28%, 0 = 0.71), emergency department visits (-37%, P = 0.44), and imaging studies (-25 to -86%) were observed. In addition, 65% fewer patients (P = 0.16) used steroids long term. IBD-related costs were 16% ($771) lower than expected (P = 0.24). Conclusion These are the first results of a successfully implemented VBHC program for IBD. Encouraging trends toward fewer emergency department visits, hospitalizations, and long-term corticosteroid use were observed. These results will need to be confirmed in a larger sample with more follow-up. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.